Peter Gallagher
#183,905
Most Influential Person Now
British neuropsychologist
Peter Gallagher's AcademicInfluence.com Rankings
Peter Gallagherpsychology Degrees
Psychology
#4271
World Rank
#4766
Historical Rank
Neuropsychology
#145
World Rank
#148
Historical Rank
Peter Gallagherbiology Degrees
Biology
#15442
World Rank
#19419
Historical Rank
Neuroscience
#2769
World Rank
#2842
Historical Rank
Download Badge
Psychology Biology
Peter Gallagher's Degrees
- Bachelors Psychology University of Manchester
- Masters Neuropsychology University of Oxford
Similar Degrees You Can Earn
Why Is Peter Gallagher Influential?
(Suggest an Edit or Addition)Peter Gallagher's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. (2006) (889)
- Neurocognitive impairment in drug-free patients with major depressive disorder (2003) (547)
- Neurocognitive impairment in euthymic patients with bipolar affective disorder (2005) (404)
- Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder (2004) (318)
- Improvements in Neurocognitive Function and Mood Following Adjunctive Treatment with Mifepristone (RU-486) in Bipolar Disorder (2004) (292)
- Neuropsychological Impairment in Major Depression: Its Nature, Origin and Clinical Significance (2007) (223)
- Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients. (2002) (210)
- Corticosteroid-serotonin interactions in depression: a review of the human evidence (2004) (171)
- Neuropsychological dysfunction, soft neurological signs and social disability in euthymic patients with bipolar disorder (2006) (158)
- Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder (2007) (135)
- Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential (2005) (130)
- Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community. (2007) (129)
- Methodological recommendations for cognition trials in bipolar disorder by the International Society for Bipolar Disorders Targeting Cognition Task Force (2017) (128)
- Assessing cortisol and dehydroepiandrosterone (DHEA) in saliva: effects of collection method (2006) (126)
- Assessing and addressing cognitive impairment in bipolar disorder: the International Society for Bipolar Disorders Targeting Cognition Task Force recommendations for clinicians (2018) (114)
- A Randomized Trial to Examine the Effect of Mifepristone on Neuropsychological Performance and Mood in Patients with Bipolar Depression (2012) (104)
- Childhood trauma in bipolar disorder (2014) (102)
- The neurocognitive profile of mood disorders – a review of the evidence and methodological issues (2015) (102)
- Effects of the menstrual cycle on mood, neurocognitive and neuroendocrine function in healthy premenopausal women (2004) (91)
- The dex/CRH test—Is it better than the DST? (2006) (89)
- Sleep and circadian rhythm disturbance in bipolar disorder (2017) (83)
- The neurocognitive performance of drug‐free and medicated euthymic bipolar patients do not differ (2009) (80)
- White matter microstructural abnormalities in euthymic bipolar disorder (2010) (79)
- Prevalence of cognitive impairment in major depression and bipolar disorder (2018) (77)
- Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes. (2005) (68)
- Effects of acute tryptophan depletion on executive function in healthy male volunteers (2003) (65)
- Dysfunctional brain dynamics and their origin in Lewy body dementia (2019) (60)
- The Effects of Acute Tryptophan Depletion on Neuropsychological Function (2003) (60)
- Effects of adjunctive mifepristone (RU-486) administration on neurocognitive function and symptoms in schizophrenia (2005) (59)
- Predictors of the discrepancy between objective and subjective cognition in bipolar disorder: a novel methodology (2016) (58)
- Affective cognition in bipolar disorder: A systematic review by the ISBD targeting cognition task force (2019) (55)
- Dynamic functional connectivity changes in dementia with Lewy bodies and Alzheimer's disease (2019) (52)
- White Matter and Cognitive Decline in Aging: A Focus on Processing Speed and Variability (2014) (51)
- Functional connectivity in dementia with Lewy bodies: A within‐ and between‐network analysis (2017) (51)
- Effects of intrinsic and extrinsic motivation on attention and memory. (2012) (50)
- Neural correlates of attention‐executive dysfunction in lewy body dementia and Alzheimer's disease (2015) (48)
- Neurocognitive Function Following Remission in Major Depressive Disorder: Potential Objective Marker of Response? (2007) (47)
- Family history, early adversity and the hypothalamic-pituitary-adrenal (HPA) axis: Mediation of the vulnerability to mood disorders (2007) (46)
- Acute tryptophan depletion in schizophrenia (2001) (46)
- Mifepristone (RU-486) treatment for depression and psychosis: a review of the therapeutic implications (2006) (43)
- Facial expression perception: an objective outcome measure for treatment studies in mood disorders? (2005) (43)
- Changes in Brain-Derived Neurotrophic Factor Following Treatment with Mifepristone in Bipolar Disorder and Schizophrenia (2007) (42)
- Neuropsychological functioning in health and mood disorder: Modulation by glucocorticoids and their receptors (2009) (42)
- A study of wrist-worn activity measurement as a potential real-world biomarker for late-life depression (2016) (40)
- Grey and white matter differences in Chronic Fatigue Syndrome – A voxel-based morphometry study (2017) (39)
- Cortisol/DHEA Ratios in Depression (2002) (38)
- Neurocognitive functioning in bipolar depression: a component structure analysis (2013) (37)
- Abnormalities of the HPA axis in affective disorders: clinical subtypes and potential treatments (2006) (37)
- Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial. (2016) (37)
- Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia. (2008) (35)
- Elevated prolactin responses to l-tryptophan infusion in medication-free depressed patients (2003) (34)
- Effects of age on a real-world What-Where-When memory task (2015) (33)
- Neurocognitive intra-individual variability in mood disorders: effects on attentional response time distributions (2015) (32)
- Central glucocorticoid receptor-mediated effects of the antidepressant, citalopram, in humans: A study using EEG and cognitive testing (2012) (32)
- Effects of acute tryptophan depletion on mood and cognitive functioning in older recovered depressed subjects. (2005) (32)
- Effects of acute tryptophan depletion on cognitive function in euthymic bipolar patients (2002) (30)
- Divergent functional connectivity during attentional processing in Lewy body dementia and Alzheimer's disease (2017) (30)
- Post-dexamethasone arginine vasopressin levels in patients with severe mood disorders. (2006) (29)
- Basal activity of the hypothalamic–pituitary–adrenal axis in patients with depersonalization disorder (2001) (29)
- Cortisol awakening response and spatial working memory in man: a U‐shaped relationship (2014) (28)
- The association between sleep and cognitive abnormalities in bipolar disorder (2019) (27)
- The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder (2006) (27)
- Dynamic functional connectivity changes in dementia with Lewy bodies and Alzheimer’s disease (2018) (25)
- Performance monitoring and executive control of attention in euthymic bipolar disorder: Employing the CPT-AX paradigm (2013) (24)
- Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome: Capturing the Discrepancy (2017) (23)
- Abnormal response to failure in unmedicated major depression. (2009) (22)
- An exploration of testosterone levels in patients with bipolar disorder (2015) (19)
- Test–retest reliability and task order effects of emotional cognitive tests in healthy subjects (2016) (18)
- Processing of Facial Emotion in Bipolar Depression and Euthymia (2015) (17)
- The impact and measurement of social dysfunction in late‐life depression: an evaluation of current methods with a focus on wearable technology (2017) (17)
- Deep learning-based automated speech detection as a marker of social functioning in late-life depression (2020) (17)
- Effects of rapid tryptophan depletion on salivary cortisol in older people recovered from depression, and the healthy elderly (2007) (16)
- Improvement of Severe Fatigue Following Nuclease Therapy in Patients With Primary Sjögren’s Syndrome: A Randomized Clinical Trial (2020) (16)
- A simple method for optimising transformation of non‐parametric data: an illustration by reference to cortisol assays (2016) (16)
- Fractionation of visuo-spatial memory processes in bipolar depression: a cognitive scaffolding account (2014) (15)
- Impairments in cognitive performance in chronic fatigue syndrome are common, not related to co-morbid depression but do associate with autonomic dysfunction (2019) (15)
- Lithium, arginine vasopressin and the dex/CRH test in mood disordered patients (2007) (15)
- The effect of pacemaker mode on cognitive function (2005) (14)
- Sex differences in object location memory: Some further methodological considerations (2006) (13)
- Are current chronic fatigue syndrome criteria diagnosing different disease phenotypes? (2017) (12)
- The International Consortium Investigating Neurocognition in Bipolar Disorder (ICONIC‐BD) (2019) (12)
- The effects of sub-chronic administration of hydrocortisone on hormonal and psychological responses to L-tryptophan in normal male volunteers (2002) (12)
- Structural correlates of attention dysfunction in Lewy body dementia and Alzheimer’s disease: an ex-Gaussian analysis (2019) (11)
- Nuclease Therapy Improves Severe Fatigue in Primary Sjögren's Syndrome: A Randomized Clinical Trial. (2020) (11)
- Effect of aspirin on hypothalamic–pituitary–adrenal function and on neuropsychological performance in healthy adults: a pilot study (2009) (10)
- Language in schizophrenia and aphasia: the relationship with non-verbal cognition and thought disorder (2019) (10)
- Distinct cognitive phenotypes in Alzheimer's disease in older people (2013) (9)
- The Neuropsychological Profile of Mild Cognitive Impairment in Lewy Body Dementias (2019) (9)
- Structural Brain Correlates of Attention Dysfunction in Lewy Body Dementias and Alzheimer’s Disease (2018) (9)
- Periventricular white matter integrity and cortisol levels in healthy controls and in euthymic patients with bipolar disorder: an exploratory analysis. (2013) (9)
- OP0202 EFFECT OF RSLV-132 ON FATIGUE IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME – RESULTS OF A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY (2019) (9)
- Randomised controlled cognition trials in remitted patients with mood disorders published between 2015 and 2021: A systematic review by the International Society for Bipolar Disorders Targeting Cognition Task Force (2022) (8)
- Study protocol for the randomised controlled trial: Antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study) (2013) (8)
- Randomised controlled trial of Antiglucocorticoid augmentation (metyrapone) of antiDepressants in Depression (ADD Study) (2015) (8)
- Phenytoin, an anti-bipolar anticonvulsant: a potential anti-glucocorticoid mechanism? (2006) (7)
- Lessons from a pilot and feasibility randomised trial in depression (Blood pressure Rapid Intensive Lowering And Normal Treatment for Mood and cognition in persistent depression (BRILiANT mood study)) (2015) (6)
- How does intentionality of encoding affect memory for episodic information? (2016) (6)
- The Impact of Target Frequency on Intra-Individual Variability in Euthymic Bipolar Disorder: A Comparison of Two Sustained Attention Tasks (2016) (6)
- A Real-world What-Where-When Memory Test. (2017) (5)
- Effect of sub-chronic hydrocortisone on responses to amphetamine in normal male volunteers (2004) (5)
- Cognitive effects of acute tryptophan depletion in the healthy elderly (2008) (5)
- Can the Cortisol to DHEA Molar Ratio be Used as a Peripheral Biomarker for Schizophrenia and Mood Disorders (2009) (5)
- Neuropsychological Impairments and Their Cognitive Architecture in Mild Cognitive Impairment (MCI) with Lewy Bodies and MCI-Alzheimer's Disease. (2021) (5)
- The relationship between physical activity, BMI, circadian rhythm, and sleep with cognition in bipolar disorder (2020) (4)
- Improved self‐esteem and activity levels following a 12‐week community activity and healthy lifestyle programme in those with serious mental illness: A feasibility study (2020) (4)
- Antiglucocorticoid treatments for mood disorders (Withdrawn Paper. 2015, Art. no. CD005168) (2015) (4)
- The effect of self-monitoring on Wisconsin Card Sorting Test performance in euthymic patients with bipolar disorder: a pilot study (2016) (4)
- Antiglucocorticoid treatments in mood disorders: efficacy and safety (2005) (3)
- Sleep disturbance: a potential target to improve symptoms and quality of life in those living with psychosis (2020) (3)
- A study of wrist-worn activity measurement as a potential real-world biomarker for late life depression (2016) (2)
- Clinical analysis of cognitive dysfunction in euthymic bipolar disorder (2006) (2)
- The dex/CRH test and the DST in patients with bipolar disorder and major depressive disorder (2007) (2)
- Neurocognitive impairment in euthymic patients Neurocognitive impairment in euthymic patients with bipolar affective disorder with bipolar affective disorder (2005) (2)
- The Neuropsychology of Mood Disorders (2004) (2)
- Neuropsychology of Bipolar Disorder. (2020) (1)
- The effects of glucocorticoid antagonists in unipolar and bipolar disorders [abstract] (2002) (1)
- Brain-derived neurotrophic factor in patients with remitted depression. (2005) (1)
- Can magnetic resonance imaging enhance the assessment of potential new treatments for cognitive impairment in mood disorders? A systematic review and position paper by the International Society for Bipolar Disorders Targeting Cognition Task Force (2022) (1)
- Visuo-spatial memory in bipolar depression: Neuropsychological and HPA axis correlates (2011) (1)
- Stilettos and Schizophrenia (2005) (1)
- Neurocognitive dysfunction in mood disorders (2003) (1)
- Efficacy of Mifepristone (RU-486) in the Treatment of Bipolar Depression (2009) (1)
- WITHDRAWN: Antiglucocorticoid treatments for mood disorders. (2015) (1)
- Commentary: Neurocognitive dysfunction in mood disorders (2003) (1)
- Mifepristone (RU-486) in the treatment of bipolar disorder and schizophrenia (2003) (1)
- 244. Neuropsychological function in drug-free depressives (2000) (1)
- The efficacy of mifepristone in bipolar depression - Effect on spatial working memory (2011) (0)
- A quantitative analysis of the relationship between affective state and personality ratings in inpatient depression (RAPID). (2022) (0)
- Neurocognitive and neuroendocrine effects of mifepristone (RU-486) in schizophrenia (2004) (0)
- THE EFFICACY OF MIFEPRISTONE IN BIPOLAR DEPRESSION- EFFECT ON MOOD SYMPTOMS (2011) (0)
- Categorical and coordinate relations in visuo-spatial memory: exploring time course and spatial displacement (2012) (0)
- Applications of Virtual Reality Technology in the Measurement of Spatial Memory in Patients with Mood Disorders (2006) (0)
- Improving neuropsychological function in bipolar disorder with antiglucocorticoids (2010) (0)
- Numbers analysed and descriptive statistics (2015) (0)
- Nonpharmacologic Treatment of Atrial Fibrillation (2002) (0)
- The Effects of Noninvasive Vagus Nerve Stimulation on Fatigue in Participants With Primary Sjögren's Syndrome. (2022) (0)
- Effects of the Oral Contraceptive Pill on Executive Function and Working Memory (2011) (0)
- Spatial memory processes in bipolar depression : neuropsychological and HPA axis correlates (2011) (0)
- Immersive virtual reality assessment of spatial memory in patients with mood disorders (2006) (0)
- Neurocognitive impairment in drug-free patients Neurocognitive impairment in drug-free patients with major depressive disorder with major depressive disorder (2003) (0)
- Effect of repeating neuropsychological tasks containing emotional stimuli (2013) (0)
- affective disorder Neurocognitive impairment in euthymic patients with bipolar (2011) (0)
- 071 Neuropsychological effects of sleep disturbance in healthy subjects (2012) (0)
- Correlations Between Periventricular White Matter Diffusion Parameters and Salivary Cortisol Levels in Euthymic Bipolar Patients and in Control Subjects (2009) (0)
- Can impairment in visualization contribute to poor visuospatial working memory performance in Major Depressive Disorder (2012) (0)
- What-Where-When memory, unlike other cognitive abilities, is unimpaired in healthy people over 70 (0)
- P.2.d.015 Is cognitive dysfunction in bipolar disorder related to sleep abnormalities? (2017) (0)
- S003329172000210Xjra 467..475 (2022) (0)
- AB0193 THE EFFECTS OF NON-INVASIVE VAGUS NERVE STIMULATIONON FATIGUE AND NEUROCOGNITION IN PARTICIPANTS WITH PRIMARY SJÖGREN’S SYNDROME (2019) (0)
- Correlation Between Ability to Potentiate Visual Evoked Potentials and Memory Performance in Healthy Subjects (2013) (0)
- Cognitive dysfunction and thetreatment of bipolar disorder (2011) (0)
- Visuo Spatial Working Memory in affective disorders: a mnemonic or attentional difficulty (2011) (0)
- Hypothalamic ^ pituitary ^adrenal axis function Hypothalamic ^ pituitary ^adrenal axis function in patients with bipolar disorder in patients with bipolar disorder (2004) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Peter Gallagher?
Peter Gallagher is affiliated with the following schools:
